Vasoactive intestinal peptide signaling axis in human leukemia

doi:10.4331/wjbc.v2.i6.146

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7531)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

536

HTML

6220

Figures (1-7)

571

Tables (1-1)

204

Sum=7531

Jun 26, 2011 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Biol Chem. Jun 26, 2011; 2(6): 146-160
Published online Jun 26, 2011. doi: 10.4331/wjbc.v2.i6.146

Full Size Figure Download Figure

Figure 3 Binding selectivity of the vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptors. Pituitary adenylate cyclase activating polypeptide receptor 1 (PAC1) selectively binds pituitary adenylate cyclase activating polypeptide (PACAP) with 1000-fold greater affinity than vasoactive intestinal peptide (VIP), whereas vasoactive intestinal peptide receptor (VPAC)1 and VPAC2 bind VIP and PACAP with equal affinity.

Citation: Dorsam GP, Benton K, Failing J, Batra S. Vasoactive intestinal peptide signaling axis in human leukemia. World J Biol Chem 2011; 2(6): 146-160
URL: https://www.wjgnet.com/1949-8454/full/v2/i6/146.htm
DOI: https://dx.doi.org/10.4331/wjbc.v2.i6.146